KAZIA THERAPEUTICS-SPON ADR (KZIA)
US48669G1058 - ADR
Kazia Therapeutics Announces Granting of Type C Meeting with FDA to Discuss Potential Next Steps for Paxalisib in the Treatment of Newly Diagnosed Glioblastoma Multiforme
/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, announced that the U.S. Food and Drug Administration...
Breast Cancer Awareness Month Sees Biotech Advancements and Worrying Trends for Young Women
/PRNewswire/ -- With every October, breast cancer awareness surges thanks to very effective campaigns and new developments in breast cancer treatment. However,...
Kazia Therapeutics Announces Presentation of Promising Phase I Data Evaluating Concurrent Paxalisib and Radiation Therapy in Patients with Solid Tumor Brain Metastases or Leptomeningeal Metastases Harboring PI3K Pathway Mutations at the American Society
/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, announced the presentation of data from a Phase I...
Kazia Therapeutics Announces Presentation of EVT801 Clinical Data at 15th Biennial Ovarian Cancer Research Symposium
/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, is pleased to announce the presentation of data...
KAZIA EXECUTES LICENSING AGREEMENT WITH QIMR BERGHOFER
/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, is pleased to announce that an agreement has been...
7 Top Stocks Under $10: July 2024 Edition
There are more than 2,100 stocks under $10 from which to choose in the market. If you want to find the best, use the Portfolio Grader.
Kazia Therapeutics Stock: Is KZIA a Buyout Candidate in the Making?
Kazia Therapeutics stock soared after positive clinical trials, which raises its profile amongst pharmas looking to buy promising candidates.
Biotech Stock Laboratory: Try a Small Experiment With Kazia Therapeutics
Kazia Therapeutics stock is a fast mover in both directions and has long-term rally potential after Kazia Therapeutics' clinical victory.
From Pennies to Dollars: 3 Sub-$5 Stocks Set to Explode Higher
If you’ve read all the warnings and still want to jump into some of the top penny stocks to buy, focus on the key fundamentals.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Silk Recalls 2024: What to Know as Plant-Based Milk Recalled Over Listeria Concerns
Silk recalls are a hot topic on Thursday as the plant-based milk alternative is being pulled from shelves due to listeria concerns.
FCEL Stock Alert: FuelCell Energy Pops on Korean Market Update
FuelCell Energy stock is up on Thursday as FCEL investors are excited about the company's Korean presentation and expansion news.
JOBY Stock Pops After Completing 523-Mile eVTOL Flight
Joby Aviation stock is flying higher on Thursday after the eVTOL company reported a new milestone for a hydrogen-electric aircraft.
KZIA Stock Alert: Kazia Continues Its Surge on Thursday With 51% Gains
Kazia Therapeutics stock is still rallying on Thursday with heavy trading of KZIA alongside its latest positive clinical trial data.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are a hot topic on Thursday and we have breakdowns of all the latest news affecting shares this morning!
KBW Just Cut Its Price Target on SoFi (SOFI) Stock
SoFi Technologies stock is up on Wednesday even after investors saw shares of SOFI stock hit with a reduced price target.
Why Is Hawaiian Electric (HE) Stock Up 15% Today?
Hawaiian Electric stock is up on Wednesday after HE investors learned of a reported settlement tied to the 2023 Maui fires.
PLUG Stock: Plug Power Shares Hydrogen Refueling Station Update
Plug Power stock is up on Wednesday after the company provided investors with an update on its hydrogen refueling stations in Europe.
Why Is Kazia Therapeutics (KZIA) Stock Up 300% Today?
Kazia Therapeutics stock is heading higher on Wednesday as KZIA investors celebrate positive clinical trial news from the company.